Paul, Weiss advised the underwriters on the IPO. Ivanhoe Electric Inc. executed its $169 million initial public offering. The offering included 14,388,000 common stock shares priced at...
Ivanhoe Electric’s $169 Million Initial Public Offering
Orchestra BioMed’s Merger with Health Sciences Acquisitions Corporation 2
Paul Hastings LLP advised Orchestra BioMed on the deal. Loeb & Loeb LLP served as legal counsel for HSAC2. Latham & Watkins LLP represented the capital...
Leumi’s NIS2.75 Billion Capital Raising
Latham & Watkins has advised Citi, Barclays, and Jefferies as global coordinators and placing agents on the deal. Bank Leumi announced its NIS2.75 billion capital raising as...
Cogent Biosciences’ $150 Million Upsized Shares Offering and Pre-funded Warrants
Latham & Watkins represented the underwriters in the offering. Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases,...
Hayward Holdings’ $348 Million Secondary Offering
Ropes & Gray advised Hayward, while Davis Polk advised the several underwriters in the offering. Hayward Holdings, Inc. executed a $348 million follow-on public offering of its...
Deciphera Pharmaceuticals’ $172.5 Million Stock and Pre-Funded Warrants Offering
Davis Polk advised the joint book-running managers, J.P. Morgan Securities LLC and Jefferie, in the offering. Deciphera Pharmaceuticals, Inc. executed a $172.5 million SEC-registered common stock and...
Hillman Solutions Corp.’s $130 Million Common Stock Offering
Latham & Watkins represented the underwriters in the offering. Hillman Solutions Corp., a leading provider of hardware products and merchandising solutions, has announced the upsize and...
Xponential Fitness’ Common Stock Offering
Davis Polk advised Xponential Fitness, while Latham & Watkins represented the underwriters in the offering. Xponential Fitness, Inc., the largest global franchisor of boutique fitness brands,...
Travere Therapeutics’ $275 Million Convertible Senior Notes Offering
Latham & Watkins represented the underwriters in the offering. Travere Therapeutics, Inc. executed its offering of US$275 million aggregate principal amount of 2.25% convertible senior notes due...
Peabody’s $275 Million Convertible Senior Notes Offering
Latham & Watkins represented the initial purchasers in the offering. Peabody, a leading coal producer, has announced the pricing of its offering of US$275,000,000 aggregate principal amount...
Vaxcyte’s $100 Million Shares Offering
Latham & Watkins represented the underwriters in the transaction. Vaxcyte, Inc. (Nasdaq: PCVX), a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of...
NETSTREIT’s Common Stock Offering
Vinson & Elkins advised the underwriters on the deal. NETSTREIT Corp. announced its public offering of 9,000,000 shares of its common stock at a price to the...